Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma
The purpose of this study is to determine whether rhuMAb VEGF (Bevacizumab) is safe and effective for the treatment of renal cell cancer when other treatments have failed.
Renal Cell Cancer
DRUG: rhuMAb VEGF (Bevacizumab)
The purpose of this study is to determine whether rhuMAb VEGF (Bevacizumab) is safe and effective for the treatment of renal cell cancer when other treatments have failed.